Navigation Links
Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc. for AeroChamber Plus(R) Brand in the US - Extends its Franchise with Pediatricians
Date:8/19/2008

MUMBAI, India and BALTIMORE, Aug. 19 /PRNewswire/ -- Lupin Ltd. announced today that the Company has entered into a multi-year promotion and marketing agreement for the AeroChamber Plus(R) line of products with Forest Laboratories, Inc. Under the terms of the agreement, Lupin Pharmaceuticals, Inc., USA, will use its 50 person sales force to promote the product to pediatricians.

AeroChamber Plus(R) is a Valved Holding Chamber (VHC) device that is used with metered dose inhalers to improve the delivery of medication to the lungs in the treatment of asthma and COPD. AeroChamber Plus(R) also reduces the deposition of medication in the mouth and throat and makes metered dose inhalers easier for patients to use by reducing the need to coordinate actuation of the inhaler with inhalation. AeroChamber Plus(R) is the most widely prescribed holding chamber in the United States and has been used by millions of patients since its introduction. Approximately two thirds of AeroChamber Plus(R) Valved Holding Chamber prescriptions (IMS 2007 data) are written by pediatricians.

"We are happy to strike this alliance with Forest. While the AeroChamber Plus(R) brand has a strong position in the Valved Holding Chamber market, we believe that this marketing alliance presents a significant opportunity for further growth of the franchise for Forest, resulting in value for both companies," said Vinita Gupta, President, LPI.

This agreement with Forest Laboratories, Inc. reflects Lupin's commitment to bring value additions to the US market to improve the overall health of the patient population. This alliance will also extend Lupin's presence in the respiratory segment and help strengthen its franchise with pediatricians.

About Lupin

Lupin Pharmaceuticals, Inc., headquartered in Baltimore, Maryland, is the wholly owned U.S. subsidiary of Mumbai based Lupin Limited, a leading Indian Pharmaceutical company. Lupin Limited develops, manufactures and markets
'/>"/>

SOURCE Lupin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Lupin Receives USFDA Approval for Divalproex Sodium Delayed-Release Tablets
2. Lupin Enters Into Marketing Alliance with ASCEND Therapeutics for Suprax(R) 400 mg Tablets in the U.S.
3. Lupin Receives USFDA Approval for Escitalopram Oxalate Tablets
4. Lupin Launches Ramipril Capsules
5. Lupin Receives USFDA Approval for Topiramate Tablets
6. Older Patients Less Likely to Be Taken to Trauma Centers
7. VA Opening Rural Health Resource Centers
8. AUDIO from Medialink and Pfizer: Community Health Centers Celebrated for Making Quality Care Available to Uninsured Americans
9. Nighttime Care Centers Introduce Mini C-Arm Mobile X-Ray Technology to Anne Arundel County
10. IPC The Hospitalist Company Enters Ohio and Pennsylvania Markets
11. Bederra Corp.s Lumar Imaging Division Enters Into Joint Venture With Basic Solutions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...-- Major medical errors self-reported by American ...depression. Those findings appear today in the onl...c-led study included collaborators from Johns Hopk...n the confidential study, nearly 9 percent of U.S....in the three months prior to being surveyed. Over ...
(Date:11/23/2009)... The Infectious Diseases Society of America (IDSA...stration and the European Union to further the Soc...w antibiotics within the next 10 years, known as t...tion (WHO) has identified antimicrobial resistance...lth. , A new European Union report confirms ther...
(Date:11/23/2009)...e-based settings get far more screen time than th..., MONDAY, Nov. 23 (HealthDay News) --Young childre...n every day than previous reports have found, espe... study finds. , Researchers from Seattle Childr...veyed day-care directors to find out how much tele...
(Date:11/23/2009)... iCRco is proud to announce its participatio...ived the highest grade possible amongst all major ...e rated “A” in sales, service and tech...ction in software functionality. iCRco is very ple...the most prestigious research firm in medical imag...
(Date:11/23/2009)...Pa.,Nov.23/PRNewswire/--UnitedConcordiaDental,oneo...newlyredesignedWebsite,www.unitedconcordia.comwhic...ducers,employersanddentists. ,, "Thesiteboastsa...n,allgearedtowardhelpingvisitorsfindinformationqui...,se-commerceprojectdirector."Fresh,relevantcontent...
Breaking Medicine News(10 mins):Health News:Burnout and mental distress strongly related to errors by US surgeons 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3Health News:Day Care Boosts Kids' TV Time 2Health News:Day Care Boosts Kids' TV Time 3Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 2Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 3
...lif., January 8 Align Technology,Inc. (Nasdaq: ...oday that the,Company will report fourth quarter a..., January 28, 2009 after the close of market. Fina...tp://investor.aligntech.com . , Following the ...
...if., Jan. 8 TEAC America, Inc. launches its,next ...ter, currently the,fastest thermal dye-sublimation...e Las Vegas Convention Center, January 8-11, 2009....d AL550S, customers can print up to 68 discs per h...
...g Drugs Will Not Surpass Vyvanse as the Clinical G...ion Resources , , WALTHAM, Mass., Jan. 8 Decisio...nd advisory firms focusing on pharmaceutical and h...icit/hyperactivity disorder (ADHD) with no risk of...
...alif., Jan. 8 Genomic Health,Inc. (Nasdaq: GHDX...Popovits as,chief executive officer. Formerly pre... the president and CEO of Genomic Health. In addi...Popovits. , "Kim,s appointment as CEO reflects...
...int) and FirstDoc (Documentum) Solutions Deliver R...pabilities , , FALLS CHURCH, Va., Jan. 8 CSC (NY...rstPoint and FirstDoc enterprise content managemen...on needs of global life science organizations. Sev...
...force hospitals to reconsider or defer purchases o...arch Group , , WALTHAM, Mass., Jan. 8 According ... for PACS, RIS, and CVIS 2009 report, the budgeta...ogy information systems (RIS), and cardiovascular ...
Other Medicine News:Health News:Align Technology to Announce Fourth Quarter and Fiscal Year 2008 Results on January 28, 2009 2Health News:TEAC America Launches its Next Generation P-55C Printer, World's Fastest Dye-Sublimation Disc Printer 2Health News:Physicians Express Continued Need for Safe and Effective Nonstimulant Therapies in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder 2Health News:Physicians Express Continued Need for Safe and Effective Nonstimulant Therapies in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder 3Health News:Genomic Health Announces Management Changes and New Responsibilities 2Health News:Genomic Health Announces Management Changes and New Responsibilities 3Health News:Genomic Health Announces Management Changes and New Responsibilities 4Health News:CSC Announces New Releases of Enterprise Content Management Solutions for Life Sciences Industry 2Health News:CSC Announces New Releases of Enterprise Content Management Solutions for Life Sciences Industry 3Health News:Budgetary Constraints on Health Care Facilities to Affect PACS, RIS, and CVIS Markets 2
(Date:11/23/2009)...NVILLE,Pa.,Nov.23/PRNewswire-FirstCall/--WestPharm...atthecompany,sChiefOperatingOfficerMatthewT.Mullar...dentandformerChiefOperatingOfficerStevenA.Ellers,5...rdertoprovidemanagerialcontinuityandsupportfollowi... Westisaglobalmanufacturerofcomponentsandsystemsfo...
(Date:11/23/2009)...NGECOUNTY,Calif.,Nov.23/PRNewswire-FirstCall/--Bec...ufacturer,andmarketerofproductsthatsimplify,automa...daythatAllanHarris,BeckmanCoulter,svicepresidentof...ferenceonWednesday,December2,2009at12:00p.m.(ET). ...0031202/BECLOGO ) ,, ThelivewebcastofBeckmanCou...
(Date:11/23/2009)...YORK,Nov.23/PRNewswire/--Reportlinker.comannounces...gue. ,, TheFutureoftheDiagnosticImagingMarkett...3/The-Future-of-the-Diagnostic-Imaging-Market-to-2...mp;utm_campaign=prnewswire ,, Description ... ,, Summary ,, GlobalMarketsDirect,s"TheFu...
Breaking Medicine Technology:Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 2Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 3Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 4Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 5Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 6Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 7Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 8Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 9Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 10Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 11West Wireless Health Institute Teams with Corventis for its First Multicenter Randomized Clinical Trial 4638 1West Wireless Health Institute Teams with Corventis for its First Multicenter Randomized Clinical Trial 4638 2West Wireless Health Institute Teams with Corventis for its First Multicenter Randomized Clinical Trial 4638 3West Wireless Health Institute Teams with Corventis for its First Multicenter Randomized Clinical Trial 4638 4New England Journal of Medicine Study Highlights Need for Rapid PCR based Group B Streptococcus 28GBS 29 Testing at Time of Admission for Labor and 12759 1New England Journal of Medicine Study Highlights Need for Rapid PCR based Group B Streptococcus 28GBS 29 Testing at Time of Admission for Labor and 12759 2New England Journal of Medicine Study Highlights Need for Rapid PCR based Group B Streptococcus 28GBS 29 Testing at Time of Admission for Labor and 12759 3New England Journal of Medicine Study Highlights Need for Rapid PCR based Group B Streptococcus 28GBS 29 Testing at Time of Admission for Labor and 12759 4DiaGenic to Provide MCI Biomarkers for Merz Pharmaceuticals 49862 1DiaGenic to Provide MCI Biomarkers for Merz Pharmaceuticals 49862 2DiaGenic to Provide MCI Biomarkers for Merz Pharmaceuticals 49862 3
...s Presented at Endocrine Society,s 90th Annual Mee...e 16 ,Bionovo, Inc. (Nasdaq: BNVI ) today announc...n breast cancer growth regulation. The data, which...al Meeting, showed that in,breast cancer cells the...or,beta results in growth arrest., "Breast cancer...
...Calif., June 16 SuperGen Inc.,(Nasdaq: SUPG ), a..., rapid,development and commercialization of thera...es, today announced at the 13th Congress of the,Eu... Denmark, that,SGI-1252, its JAK2 kinase inhibitor...act #741)., In an oral presentation titled "SGI-1...
Other Medicine Technology:Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta 2Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta 3SuperGen's JAK2 Inhibitor, SGI-1252, Inhibits in Vivo Tumor Cell Proliferation 2
OES BF-3C40 Bronchoscope
...est full-featured bronchofiberscope yet. The BF-3C...d by 0.2mm from the previous model. It also offers...models, thanks to the use of extra-fine optical fi...size by 70 percent. Images are clearer, bigger, an...
...0, the first in a series of bronchofiberscopes wit...eatures necessary to meet the demand for expanded ...s. The scope includes a new control section and er...mfort. It also provides a wider field of view, a s...
Broncho-Cath® Endobronchial Tube with CPAP System
Medicine Products: